Clinical trial
Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil
NCT00474201 · National Institutes of Health Clinical Center (CC), NIH · Completed
Key facts
| NCT number | NCT00474201 |
|---|---|
| Title | Drug Interaction Study of Lopinavir/Ritonavir and Gemfibrozil |
| Official title | The Influence of Lopinavir/Ritonavir on Gemfibrozil Pharmacokinetics in Healthy Volunteers |
| Acronym | GEM-PK |
| Lead sponsor | National Institutes of Health Clinical Center (CC), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Healthy Volunteers |
| Intervention type | Drug |
| Interventions | Lopinavir/Ritonavir, Gemfibrozil |
| Enrollment | 15 |
| Start date | May 1, 2007 |
| Primary completion | Jul 1, 2008 |
| Completion | Jul 1, 2008 |
| First posted | May 16, 2007 |
| Last update posted | Sep 26, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: